A 42-year-old man with a history of chronic pancreatitis presents with acute upper GI bleeding from esophageal varices. In addition to variceal band ligation, the physician initiates pharmacotherapy targeting the hormone marked **D** in the diagram. Which of the following best explains the mechanism by which this drug reduces bleeding risk in this clinical scenario?